Skip to main content

Radiochemotherapy of Liver Metastases from Breast Cancer: Review of Literature and Personal Experience

  • Chapter
Advances in Abdominal Surgery 2002

Abstract

Breast cancer, like several other solid tumors, has the capacity to metastasize to the liver, with a dismal prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jaffe BM, Donegan WL. Factors influencing survival in patients with untreated hepatic metastasis. Surg Gynecol Obstet 1968; 127: 1–11.

    PubMed  CAS  Google Scholar 

  2. Hoe AL, Royle GT, Taylor I. Breast liver metastases — incidence, diagnosis and outcome. J R Soc Med 1991; 84 (12): 714–716.

    PubMed  CAS  Google Scholar 

  3. Santoro E, Vitucci C, Carlini M, et al. Liver metastasis of breast carcinoma. Chir Ital 2000; 52 (2): 131–137.

    PubMed  CAS  Google Scholar 

  4. Yoshimoto M, Tada T, Saito M, Takahashi K, Uchida Y, Kasumi F. Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat 2000; 59 (2): 177–1.

    Article  PubMed  CAS  Google Scholar 

  5. Selzner M, Morse MA, Vderenburgh JJ, Meyers WC, Clavien PA. Liver metastases from breast cancer: long-term survival after curative resection. Surgery 2000; 127 (4): 383–389.

    Article  PubMed  CAS  Google Scholar 

  6. Joensuu H, Holli K, Heikkinen E et al. Combination chemotherapy versus single-agent therapy as first and second line treatment in metastatic breast cancer: a prospective randomized trial. J Clin Oncol 1998; 16 (12): 3720–3730.

    PubMed  CAS  Google Scholar 

  7. Barone RM, Bayfield JE, Goldfarb PB, Frankel S, Ginn C, Greer S. Inta-arterial chemo- therapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Cancer 1982; 50: 850–862.

    Article  PubMed  CAS  Google Scholar 

  8. Sullivan R. Systemic and arterial infusion chemotherapy for metastatic liver cancer. Int J Radiat Oncol Biol Phys 1976; 1: 973–976.

    Article  PubMed  CAS  Google Scholar 

  9. Trudeau ME. Phase I-II studies oh docetaxel as single agent in the treatment of metastatic breast cancer. Semin Oncol 1999; 28 (Supp18): 21–26.

    Google Scholar 

  10. Sparano J. Novel combination chemotherapy regimens for metastatic breast cancer. The 21st San Antonio Breast cancer Simposium. December 12–15, 1998.

    Google Scholar 

  11. Cocconi G, De Lisi V, Boni C, et al. Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer. Cancer 1983; 51: 581–588.

    Article  PubMed  CAS  Google Scholar 

  12. Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation hepatitis. Am J Roentgenol 1965; 93: 200–208.

    CAS  Google Scholar 

  13. Phillips R. Roentgentherapy of hepatic metastases. Am JRoentg Ther Nucl Med 1954; 71: 826–834.

    CAS  Google Scholar 

  14. Borgelt BB, Gelber R, Brady LW, Griffin T, Hendricksson FR. The palliation of hepatic metastases: Results of the Radiation Therapy Oncology Group pilot Study. Int J Radiat Oncol Biol Phys 1981; 7: 587–591.

    Article  PubMed  CAS  Google Scholar 

  15. Heimdal K, Hannisdal E, Fossa SD. Survival after palliative radiotherapy of liver metastases. Acta Oncol 1988; 27: 63.

    Article  PubMed  CAS  Google Scholar 

  16. Kagan AR. Dose-time relationships in the palliation of metastases to liver, lung, brain and bone metastases. Front Radiat Ther Oncol 1988; 22: 165-

    Google Scholar 

  17. Thames HD, Peters LJ, Withers RH, Fletcher GH. Accelerated fractionation vs hyper fractionation. Rationale for several treatments per day. Int J Radiat Oncol Biol Phys 1983; 9: 127–138.

    Article  PubMed  Google Scholar 

  18. Thames HD, Withers RH, Peters LJ, Fletcher GH. Changes in early and late radiation response with alterated dose fractionation. Implication for dose-survival relationships. Int JRadiat Oncol Biol Phys 1982; 8: 219–226.

    Article  Google Scholar 

  19. Russell AH, Clyde C, Wasserman TH, Turner SS, Rotman M. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose esclating protocol. Int JRadiat Oncol Biol Phys 1993; 27: 117–123.

    Article  CAS  Google Scholar 

  20. Lokich J, Kinsella T, Perri J Malcom A, Clouse M. Concomitant hepatic radiation and intraarterial pyrimidine therapy: correlation of liver scan, liver function test and plasma CEA with tumor response. Cancer 1981; 48: 2569–2574.

    Article  PubMed  CAS  Google Scholar 

  21. Kinsella T.I. The role of radiation therapy alone and combined with infusion of chemotherapy for treating liver metastaes. Sem Oncol 1983; 10: 215–22.

    CAS  Google Scholar 

  22. Rotman M, Kuruvilla AM, Choi K, Bhutiani I, Aziz H, Rosentha J, Braverman A et al. Response of colo-rectal Hepatic metastases to concomitant radiotherapy and intravenous infusion 5-fluorouracil. Int J Radiat Oncol Biol Phys 1986; 12: 2179–2187.

    Article  PubMed  CAS  Google Scholar 

  23. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F. Pharmacological requirements for obtaining sensistization of human tumor cells in vitro to combined 5-fluorouracil or ftorafu and x-rays. IntJRadiat Oncol Biol Phys 1982; 8: 1923–1933.

    CAS  Google Scholar 

  24. Fu K, Rayner BS, Lam K. Modification of effects of continuous low dose irradiation by concurrent chemotherapy infusion. Int J Radial Oncol Biol Phys 1984; 10: 1473–1478.

    Article  CAS  Google Scholar 

  25. Nakajima V, Miyamoto N, Tanabe M, Watanabe I, Terasima T. Enhancement of mammalian cell killing by 5-fluorouracil in combination with x-rays. Cancer Res 1979; 39: 3763–3767.

    PubMed  CAS  Google Scholar 

  26. Nigro ND, Vaitkevicius VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17: 354–357.

    Article  PubMed  CAS  Google Scholar 

  27. Dobrowsky W, Dobrowsky E, Strassl H, Braun O, Scheibers V. response to peoperative radio-chemotherapy with mitomycin C and 5-fluorouracil in advanced head and neck cancer. EurJ Cancer Clin Oncol 1989; 25: 845–849.

    Article  CAS  Google Scholar 

  28. Steel GG, Peckham MJ. Expoitable mechanism in combined radiotherapy-chemotherapy: the concept of additivity. Int JRadiat Oncol Biol Phys 1979; 5: 85–91.

    Article  CAS  Google Scholar 

  29. Kennedy KA, Rockwell S, Sartorelli AC. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res 1980; 40: 2356–2360.

    PubMed  CAS  Google Scholar 

  30. Seifert P, Baker LH, Reed ML, Vaitkevicius VK. Comparison of continuously infused 5-Fluorouracil with bolus injection in treatment of patients with colorectal cancer. Cancer 1975; 36: 123–128.

    Article  PubMed  CAS  Google Scholar 

  31. Peretz T, Freund HR, Isacson R et al. Treatment of primary and metastatic liver cancer using an implantable chemoinfusion pump. Isr J Med Sci 1988; 24: 562–567.

    PubMed  CAS  Google Scholar 

  32. Mohiuddin M, Chen E, Ahmad N. combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol 1996; 14: 722–728.

    CAS  Google Scholar 

  33. Aray Y, Sone Y, Inaba Y, Ariyoshi Y, Kido C. Hepatic arterial infusion chemotherapy for liver metastases from breast cancer. Cancer Chemother Pharmacol 1994; 33S: 141–144.

    Google Scholar 

  34. Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP. The regional treatment of liver metastases from breast cancer. JSurg Oncol 1994; 55 (1): 26–31.

    Article  CAS  Google Scholar 

  35. Ausili Cefaro G, Smaniotto D, De Renzis C. Radiotherapy of hepatic metastases. Acta Med Rom 1986; 24: 143–148.

    Google Scholar 

  36. Nardone L, Salvi G, Brizi MG, Caspiani O, Abu Rumeileh I. Trattamento integrato radiochemioterapico concomitante per le metastasi epatiche da carcinoma mammario. In: Squillaci S: “Neoplasie epatiche e pancreatiche” — Monduzzi Editore, 1993, 253–257.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Ausili, C.G., Nardone, L., Marmiroli, G., Manfrida, S., Salvi, G. (2002). Radiochemotherapy of Liver Metastases from Breast Cancer: Review of Literature and Personal Experience. In: Farinon, A.M. (eds) Advances in Abdominal Surgery 2002. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0637-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-0637-7_9

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-6135-5

  • Online ISBN: 978-94-017-0637-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics